Literature DB >> 12403644

Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.

Jane Alcorn1, Patrick J McNamara.   

Abstract

Maturation of drug systemic clearance mechanisms during the postnatal period produces dramatic and rapid changes in an infant's capacity to eliminate drugs. A tentative general mathematical model describing the ontogeny of hepatic cytochrome P450 (CYP) enzyme-mediated clearance and renal clearance due to glomerular filtration in the first 6 months of life was elaborated from age-specific in vitro hepatic microsomal activity data (normalised to amount of hepatic microsomal protein) for enzyme-specific probe substrates and in vivo probe substrate data for glomerular filtration (normalised to bodyweight), respectively. The model predicts an age- and clearance pathway-specific Infant Scaling Factor (ISF) for the first 6 months of life. The ISF reflects functional maturation of a specific clearance pathway (normalised to bodyweight) relative to adult values. Therefore, the ISF directly correlates adult clearance values with an infant's capacity to eliminate drugs. Substitution of appropriate model parameter estimates and the age of the infant into the model provides an estimated ISF value, which may then be used to predict the contribution of a particular clearance pathway to total systemic clearance in the infant when adult systemic clearance values are known. The model was tested for its ability to predict infant systemic clearance of drugs whose elimination is principally mediated by a single CYP enzyme or by glomerular filtration. The model performed reasonably well for CYP1A2 and CYP3A4, but poorer predictions were obtained for CYP2D6 and CYP2C because of lack of model complexity and/or inadequate hepatic microsomal activity data to fully describe the maturational process of functional enzyme. For renal clearance due to glomerular filtration, data normalised to bodyweight (kg) showed a limited maturational trend, suggesting that adult renal clearances normalised to bodyweight might reasonably predict infant renal clearances in the first 6 months of life. The model provided reasonable predictions of renal clearance due to glomerular filtration in the infant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403644     DOI: 10.2165/00003088-200241130-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  77 in total

1.  MATURATION OF RENAL FUNCTION IN CHILDHOOD: CLEARANCE STUDIES.

Authors:  M I Rubin; E Bruck; M Rapoport; M Snively; H McKay; A Baumler
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

2.  Cytochrome P-450 measurement in rat liver homogenate and microsomes. Its use for correction of microsomal losses incurred by differential centrifugation.

Authors:  J G Joly; C Doyon; Y Peasant
Journal:  Drug Metab Dispos       Date:  1975 Nov-Dec       Impact factor: 3.922

3.  Maturation and growth of renal function: dosing renally cleared drugs in children.

Authors:  W L Hayton
Journal:  AAPS PharmSci       Date:  2000

Review 4.  Effect of maturation on drug disposition in pediatric patients.

Authors:  C F Stewart; E M Hampton
Journal:  Clin Pharm       Date:  1987-07

5.  The disposition of alfentanil in neonates with respiratory distress.

Authors:  D B Wiest; B L Ohning; S S Garner
Journal:  Pharmacotherapy       Date:  1991       Impact factor: 4.705

6.  Population pharmacokinetic modeling in very premature infants receiving midazolam during mechanical ventilation: midazolam neonatal pharmacokinetics.

Authors:  T C Lee; B G Charles; G J Harte; P H Gray; P A Steer; V J Flenady
Journal:  Anesthesiology       Date:  1999-02       Impact factor: 7.892

7.  Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn.

Authors:  R Latini; B M Assael; M Bonati; M L Caccamo; M Gerna; M Mandelli; A Marini; F Sereni; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

8.  Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response.

Authors:  S Ito; R Gow; Z Verjee; E Giesbrecht; H Dodo; R Freedom; G R Tonn; J E Axelson; E Zalzstein; H C Rosenberg; G Koren
Journal:  J Clin Pharmacol       Date:  1998-06       Impact factor: 3.126

9.  Gentamicin monitoring in neonates.

Authors:  G Pons; P d'Athis; E Rey; D de Lauture; M O Richard; J Badoual; G Olive
Journal:  Ther Drug Monit       Date:  1988       Impact factor: 3.681

10.  Factors influencing theophylline disposition in 179 newborns.

Authors:  J T Gilman; P Gal; R S Levine; C B Hersh; N V Erkan
Journal:  Ther Drug Monit       Date:  1986       Impact factor: 3.681

View more
  43 in total

Review 1.  Neonatal exposure to drugs in breast milk.

Authors:  Patrick J McNamara; Maggie Abbassi
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

2.  Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?

Authors:  Sven Björkman
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach.

Authors:  Esther Encinas; Rosario Calvo; John C Lukas; Valvanera Vozmediano; Monica Rodriguez; Elena Suarez
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

Review 4.  State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development.

Authors:  Venkata Yellepeddi; Joseph Rower; Xiaoxi Liu; Shaun Kumar; Jahidur Rashid; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2019-01       Impact factor: 6.447

5.  Interspecies scaling for the prediction of drug clearance in children: application of maximum lifespan potential and an empirical correction factor.

Authors:  Iftekhar Mahmood
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

6.  A mechanistic approach for the scaling of clearance in children.

Authors:  Andrea N Edginton; Walter Schmitt; Barbara Voith; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 7.  Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?

Authors:  Heinrike Schmeling; Gerd Horneff; Susanne M Benseler; Marvin J Fritzler
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

8.  Prediction of drug clearance in children: an evaluation of the predictive performance of several models.

Authors:  Iftekhar Mahmood; Carl-Michael Staschen; Kosalaram Goteti
Journal:  AAPS J       Date:  2014-10-02       Impact factor: 4.009

Review 9.  Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.

Authors:  Imke H Bartelink; Carin M A Rademaker; Alfred F A M Schobben; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 10.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.